Meloxicam Patent Expiration

Meloxicam was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Mobic on Apr 13, 2000. Other drugs containing Meloxicam are Vivlodex, Qmiiz Odt, Anjeso, Meloxicam. 30 different companies have introduced drugs containing Meloxicam.


Meloxicam Patents

Given below is the list of patents protecting Meloxicam, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Anjeso US10881663 Method of treating pain in elderly patients with mild renal impairment Mar 08, 2039 Baudax
Anjeso US11458145 Methods of administering intravenous meloxicam in a bolus dose Mar 08, 2039 Baudax
Vivlodex US9649318 Formulation of meloxicam Mar 31, 2035 Iceutica Operations
Vivlodex US9808468 Formulation of meloxicam Mar 31, 2035 Iceutica Operations
Vivlodex US9526734 Formulation of meloxicam Mar 31, 2033 Iceutica Operations
Qmiiz Odt US8545879 Fast disintegrating compositions of meloxicam Aug 31, 2030 Tersera
Anjeso US10709713 Nanoparticulate meloxicam formulations May 26, 2030 Baudax
Anjeso US11253478 Reduction of flake-like aggregation in nanoparticulate active agent compositions May 26, 2030 Baudax
Anjeso US9974746 Reduction of flake-like aggregation in nanoparticulate active agent compositions May 26, 2030 Baudax
Anjeso US10463673 Nanoparticulate meloxicam formulations Feb 24, 2024

(Expired)

Baudax
Anjeso US10471067 Nanoparticulate meloxicam formulations Feb 24, 2024

(Expired)

Baudax
Anjeso US8512727 Nanoparticulate meloxicam formulations Dec 25, 2022

(Expired)

Baudax
Meloxicam US6184220

(Pediatric)

Oral suspension of pharmaceutical substance Sep 25, 2019

(Expired)

Avondale Pharms
Meloxicam US6184220 Oral suspension of pharmaceutical substance Mar 25, 2019

(Expired)

Avondale Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Meloxicam's patents.

Given below is the list recent legal activities going on the following patents of Meloxicam.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 07 May, 2021 US9808468
Payment of Maintenance Fee, 8th Year, Large Entity 17 Mar, 2021 US8545879
Payment of Maintenance Fee, 4th Yr, Small Entity 16 Nov, 2020 US9649318
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 16 Oct, 2020 US9649318
Payment of Maintenance Fee, 4th Yr, Small Entity 29 Jun, 2020 US9526734
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 22 May, 2020 US9526734
Patent Issue Date Used in PTA Calculation 07 Nov, 2017 US9808468
Recordation of Patent Grant Mailed 07 Nov, 2017 US9808468
Email Notification 19 Oct, 2017 US9808468
Issue Notification Mailed 18 Oct, 2017 US9808468


Meloxicam's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Meloxicam Generics

Several generic applications have been filed for Meloxicam. The first generic version for Meloxicam was by Roxane Laboratories Inc and was approved on Jul 19, 2006. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Jun 7, 2023.

Given below is the list of companies who have filed for Meloxicam generic.


1. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Jul 19, 2006
15MG tablet Prescription ORAL AB Jul 19, 2006


2. ANDA REPOSITORY

Anda Repository Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006
15MG tablet Discontinued ORAL N/A Jul 19, 2006


3. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB Jun 7, 2023
7.5MG tablet Prescription ORAL AB Jun 7, 2023


4. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Oct 2, 2006
15MG tablet Prescription ORAL AB Oct 2, 2006


5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006
15MG tablet Discontinued ORAL N/A Jul 19, 2006


6. CIPLA

Cipla Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Jul 19, 2006
15MG tablet Prescription ORAL AB Jul 19, 2006


7. COREPHARMA

Corepharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB Jul 20, 2006
7.5MG tablet Prescription ORAL AB Jul 20, 2006


8. CR DOUBLE CRANE

China Resources Double Crane Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Cr Double Crane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Discontinued ORAL N/A Dec 14, 2006
7.5MG tablet Discontinued ORAL N/A Dec 14, 2006


9. DR REDDYS LABS INC

Dr Reddys Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB Jul 25, 2006
7.5MG tablet Prescription ORAL AB Jul 25, 2006


10. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Jul 19, 2006
15MG tablet Prescription ORAL AB Jul 19, 2006


11. IMPAX LABS INC

Impax Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006
15MG tablet Discontinued ORAL N/A Jul 19, 2006


12. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG capsule Prescription ORAL AB Jun 1, 2020
10MG

(reference standard)

capsule Prescription ORAL AB Jun 1, 2020


13. LUPIN PHARMS

Lupin Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Lupin Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Jul 19, 2006
15MG tablet Prescription ORAL AB Jul 19, 2006


14. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 20, 2006
15MG tablet Discontinued ORAL N/A Jul 20, 2006


15. NATCO PHARMA

Natco Pharma Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Natco Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006
15MG tablet Discontinued ORAL N/A Jul 19, 2006


16. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG capsule Prescription ORAL AB Mar 9, 2021
5MG capsule Prescription ORAL AB Mar 9, 2021


17. PURACAP PHARM

Puracap Pharmaceutical Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Puracap Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Jul 19, 2006
15MG tablet Prescription ORAL AB Jul 19, 2006


18. ROXANE

Roxane Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Discontinued ORAL N/A Jul 19, 2006
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006


19. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB May 13, 2009
7.5MG tablet Prescription ORAL AB May 13, 2009


20. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006
15MG tablet Discontinued ORAL N/A Jul 19, 2006


21. TARO

Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB Nov 7, 2006
7.5MG tablet Prescription ORAL AB Nov 7, 2006


22. UNICHEM

Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB Dec 20, 2006
7.5MG tablet Prescription ORAL AB Dec 20, 2006


23. YABAO PHARM

Yabao Pharmaceutical Co Ltd Beijing has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Yabao Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Discontinued ORAL N/A Jul 19, 2006
15MG tablet Discontinued ORAL N/A Jul 19, 2006


24. YUNG SHIN PHARM

Yung Shin Pharmaceutical Industrial Co Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Yung Shin Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG tablet Prescription ORAL AB Dec 7, 2006
7.5MG tablet Prescription ORAL AB Dec 7, 2006


25. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG tablet Prescription ORAL AB Jul 19, 2006
15MG

(reference standard)

tablet Prescription ORAL AB Jul 19, 2006